09 May, 2026

The British patient advocates the antitrust regulator to probe drug manufacturers

The UK antitrust regulator was invited by patient defense groups to investigate several major drug manufacturers and their British lobbying organization for “suspects” and “coordinated” efforts to increase the prices of medicines. The backdrop of the complaint was an ongoing row between the pharmaceutical industry and the British government for the compulsory discounts that pharmaceutical […]

1 min read

Medicines manufacturers are a new group to put pressure on the impact of negotiation of drug prices for medication

Washington – A handful of pharmaceutical companies have trained a group to present to legislators research on what industry considers the negative impacts of negotiations on Medicare drug prices, according to lobbying files. The group is called the IRA watchdog after the law on the reduction of inflation, which ordered Medicare to negotiate the prices […]

1 min read